Videos | Lexitas

How Allgenesis Evaluated Unique Endpoints to Advance its Phase

In this webinar, Sally Tucker, President of Global Services for Lexitas, is joined by the leadership team of Voxeleron and Allgenesis to discuss their collaboration on a recent phase two study for diabetic macular edema (DME). The panelists highlight the importance of imaging and biomarkers in ophthalmology clinical trials and share their experiences working with […]

From Patient Care to Research: Dr. Bruce Segal’s Journey

Welcome back to the InFocus podcast series, hosted by Dr. Andrew Pucker, Senior Director of Clinical Medical Sciences at Lexitas Pharma Surfaces. In this episode, Dr. Pucker sits down with Dr. Bruce Segal, an experienced ophthalmologist based in Delray Beach, Florida, to delve into the world of medical research. Dr. Segal shares his journey into […]

The Impact of Contact Lens Wear On the Ocular Surface w/ Dr. Joe Shovlin

In this episode of the Infocus podcast series, host Dr. Andrew Pucker is joined by Dr. Joe Shovlin to discuss the impact of contact lenses on the ocular surface. The conversation revolves around a paper from the Tear Film and Ocular Surface Society (TFOS) titled “Impact of Contact Lenses on the Ocular Surface” and its […]

Lifestyle Impact On Ocular Health w/ Dr. Sheetal Shah

In this episode of the “In Focus” podcast series, Dr. Sheetal Shah, Cornea and External Disease Specialist sits with Dr. Andrew Pucker, Senior Director of Clinical Medical Science at Lexitas Pharma Services to discuss the impact of cosmetics on the ocular surface. They delve into the findings of the Tear Film and Ocular Surface Society’s […]

How Exonate Plans to Revolutionize Diabetic Eye Disease Treatment: A Convo with Dr. Catherine Beech

In this episode of “In Focus,” Julie Schlosser sits down with Dr. Catherine Beech, CEO of biotech company Exonate, to discuss their cutting-edge work in ophthalmology. Exonate is focused on developing a groundbreaking eye drop treatment for diabetic eye disease, aiming to replace the need for invasive injections into the eye. Dr. Beech shares the […]

Overcoming Barriers to Ophthalmic Studies: Advice from the Experts YouTube (Video)

How can ophthalmic sponsors’ anticipate and prepare for the biggest challenges in their study? Check out our four-minute video that can save you weeks of frustration. With expert advice from multiple experts who have conducted hundreds of ophthalmology clinical trials. Our In Focus newsletter is published once a month and has thousands of subscribers. To help you […]

Trends in Ophthalmology Clinical Trials (Video)

Ophthalmic clinical trials are increasing in complexity, as novel endpoints, new innovations in gene therapy and advances in AI are helping to push the boundaries of what was previously possible. Listen to CRO experts in clinical operations and ophthalmology talk about the trends and opportunities in clinical studies for eye disease. Our In Focus newsletter is published […]

The State of the Ophthalmology Funding Landscape

Lexitas Pharma Services CEO and Executive Chairwoman Jeanne Hecht joins Triangle Business Journal President and Publisher Jason Christie to talk about Lexitas’ recent growth and where it’s headed as the new year approaches. See More Our In Focus newsletter is published once a month and has thousands of subscribers. To help you keep in touch, you can subscribe […]

Opportunities in the Ophthalmic Drug and Device Development Space w/ George MacGrath, via NYSE

Pharmaceutical and biotechnology companies developing ophthalmology products have their eye on Lexitas Pharma Services for clinical trial services. Hear from our own CEO George Magrath about the opportunities he sees coming out in the ophthalmic drug and device development space. Transcript: I’m Judy Shaw for NYSC floor Talk joining me today is George Magrath he is CEO at Lexitas […]

Targeting Eye Disease from a Doctor’s Perspective – Lexitas Pharma CEO George Magrath, live from NYSE

IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange with George Magrath, M.D., Chief Executive Officer of Lexitas Pharma. Dr. Magrath, who continues to practice medicine part time, spoke to IPO Edge Editor-in-Chief John Jannarone about investments in pharma and life sciences companies, how ophthalmic startups are different than other pharma startups […]

Best Practices for Anterior Segment Ophthalmology Trials w/ Dr. Joseph Tauber

Dr. Joseph Tauber and Dr. George Magrath have participated in hundreds of ophthalmology clinical trials between them. They give tips and practical advice for anterior segment studies, including Dry Eye. They also discuss the advantages of a new modified NEI grading scale for corneal fluorescein staining. Hear about the challenges in the approval process for […]

Advancing Diversity in Leadership w/ OWL Podcast

Interview with Abby Markward, Immediate Past President of OWL, and Dr. George Magrath, CEO of Lexitas. We learned more about Lexitas’s approach to diversity, inclusion and belonging. You’re also sure to enjoy George’s answers to our fun questions and one of the BEST answers to our final surprise question!